BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3712146)

  • 1. Poliovirus vaccines: live or dead.
    Ogra PL; Faden HS
    J Pediatr; 1986 Jun; 108(6):1031-3. PubMed ID: 3712146
    [No Abstract]   [Full Text] [Related]  

  • 2. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE
    Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
    [No Abstract]   [Full Text] [Related]  

  • 3. The problems of poliovirus immunization.
    Fulginiti VA
    Hosp Pract; 1980 Aug; 15(8):61-7. PubMed ID: 6249713
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined use of inactivated and oral poliovirus vaccines in a large-scale campaign in refugee camps and host communities – Kenya, December 2013.
    Wkly Epidemiol Rec; 2014 Mar; 89(12):127-32. PubMed ID: 24707518
    [No Abstract]   [Full Text] [Related]  

  • 5. Toward eradication of poliomyelitis by combined use of killed and live vaccines.
    Melnick JL
    Cardiovasc Res Cent Bull; 1982; 20(3):49-60. PubMed ID: 6805957
    [No Abstract]   [Full Text] [Related]  

  • 6. [Poliomyelitis vaccination in Denmark].
    Petersen I
    Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
    [No Abstract]   [Full Text] [Related]  

  • 7. On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine.
    Peng X; Hu X; Salazar MA
    Lancet; 2018 Aug; 392(10147):610-612. PubMed ID: 29605427
    [No Abstract]   [Full Text] [Related]  

  • 8. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis].
    Dostal V; Haenzel I; Sturm W
    Schweiz Med Wochenschr; 1969 Sep; 99(37):1322-4. PubMed ID: 4309326
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliomyelitis vaccination benefits--versus risk.
    Assaad F
    Dev Biol Stand; 1979; 43():141-50. PubMed ID: 520666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polio eradication in India: how far are we from reaching the goal?
    Banerjee K; Sahu S; Bandyopadhyay S
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S6-14. PubMed ID: 11411387
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.
    Wkly Epidemiol Rec; 2006 Apr; 81(15):137-44. PubMed ID: 16673508
    [No Abstract]   [Full Text] [Related]  

  • 13. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper.
    Wkly Epidemiol Rec; 2010 Jun; 85(23):213-28. PubMed ID: 20545051
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 15. Polio.
    McFee RB
    Dis Mon; 2013 Dec; 59(12):445-7. PubMed ID: 24314810
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunization and decrease in mortality of acute poliomyelitis].
    Laflor Carot V; Bernalte Benazet A; Carpio JM; Cornejo JA
    Rev Enferm; 1984 Jun; 7(70):22-30. PubMed ID: 6566431
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Poliomyelitis in the Netherlands].
    Dekking F
    Ned Tijdschr Geneeskd; 1978 Aug; 122(31):1142-3. PubMed ID: 673050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.